Filing Details

Accession Number:
0000884731-16-000081
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-29 16:25:15
Reporting Period:
2016-06-27
Filing Date:
2016-06-29
Accepted Time:
2016-06-29 16:25:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604646 M Hugh Cole C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Svp, Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-27 12,500 $0.00 29,262 No 4 M Direct
Common Stock Acquisiton 2016-06-27 6,666 $0.00 35,928 No 4 M Direct
Common Stock Disposition 2016-06-28 6,012 $7.05 29,916 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2016-06-27 12,500 $0.00 12,500 $0.00
Common Stock Restricted Stock Units Disposition 2016-06-27 6,666 $0.00 6,666 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
6,667 No 4 M Direct
Footnotes
  1. Shares were acquired upon the vesting of an RSU granted June 25, 2014.
  2. Shares were sold to satisfy the Company's tax withholding obligations pursuant to an irrevocable election to sell to cover taxes previously authorized by the reporting person.
  3. Vests 50% per year on each of June 25, 2015 and 2016.
  4. Vests 33 1/3% per year on each of June 25, 2015, 2016 and 2017.